Rosedale Woman Pleads Guilty to Conspiracy to Distribute Controlled Substances and Money Laundering

Defendant trafficked thousands of oxycodone pills and laundered millions of dollars.

Baltimore, Maryland – Terry Allen, 57, of Rosedale, Maryland, has pleaded guilty to conspiracy to distribute controlled substances and money laundering.

Kelly O. Hayes, U.S. Attorney for the District of Maryland, announced the guilty plea with Acting Special Agent in Charge Amanda M. Koldjeski, Federal Bureau of Investigation (FBI) – Baltimore Field Office; Special Agent in Charge Ibrar A. Mian, Drug Enforcement Administration (DEA) – Washington Division; Special Agent in Charge Maureen Dixon, Health and Human Services-Office of the Inspector General (HHS-OIG) – Philadelphia Regional Office; and Chief Robert O. McCullough, Baltimore County Police Department (BCPD).

According to the guilty plea, in 2022, during an investigation into a target, the FBI discovered that the target paid Allen more than $270,000.  Agents later learned that Allen was supplying the FBI target with diverted prescription drugs. As a result, the FBI partnered with the DEA and identified Allen as the leader of a Baltimore-region drug trafficking organization (DTO).  Agents soon learned that from 2022 to 2023, Allen’s DTO flooded the Baltimore community with thousands of diverted oxycodone pills.

The DTO’s members deployed a vast network of pseudo-patients to acquire diverted oxycodone pills.  Pseudo patients are individuals recruited by drug traffickers to enter “pill-mill” clinics with fictitious complaints of pain to receive prescriptions for Schedule II controlled substances.  As part of the conspiracy, pseudo-patients gave their oxycodone prescriptions to DTO members in exchange for cash payments or oxycodone.

In February 2023, law enforcement received court authorization to intercept phone calls and text messages from numerous DTO members’ cellular phones.  Intercepted calls revealed that Allen was distributing vast quantities of oxycodone.

Click for full Press Release.